Investors

SEC Filings

SEC Filings

Filing date	Form	Description	View
June 8, 2016	4/A	Amendment to a previously filed 4	0001562180-16-002559.pdf 0001562180-16-002559.rtf 0001562180-16-002559.xls View HTML
May 20, 2016	EFFECT	EFFECT	9999999995-16-004724.pdf 9999999995-16-004724.rtf 9999999995-16-004724.xls View HTML
May 18, 2016	CORRESP	CORRESP	0001193125-16-593872.pdf 0001193125-16-593872.rtf 0001193125-16-593872.xls View HTML
May 17, 2016	UPLOAD	UPLOAD	0000000000-16-076782.pdf View HTML
May 5, 2016	10-Q	Quarterly report which provides a continuing view of a company's financial position	0001564590-16-017968.pdf 0001564590-16-017968.rtf 0001564590-16-017968.xls EX-101.INS - XBRL INSTANCE DOCUMENT View HTML
May 5, 2016	S-3	Simplified registration form	0001193125-16-579940.pdf 0001193125-16-579940.rtf 0001193125-16-579940.xls View HTML
April 29, 2016	DEF 14A	Official notification to shareholders of matters to be brought to a vote ("Proxy")	0001193125-16-569284.pdf 0001193125-16-569284.rtf 0001193125-16-569284.xls View HTML
April 29, 2016	DEFA14A	Additional proxy soliciting materials - definitive	0001193125-16-569332.pdf 0001193125-16-569332.rtf 0001193125-16-569332.xls View HTML
April 26, 2016	CT ORDER	CT ORDER	9999999997-16-022518.pdf View HTML
April 5, 2016	4	Statement of changes in beneficial ownership of securities	0001209191-16-112923.pdf 0001209191-16-112923.rtf 0001209191-16-112923.xls View HTML

Data provided by Kaleidoscope.

Print Page

Email Page

Contact IR

Email Alerts

Tear Sheet

Akebia Therapeutics, Inc.
245 First Street, Suite 1400
Cambridge, MA 02142

Driving Directions

+1 617.871.2098 phone
+1 617.871.2099 fax